Integrated DNA Technologies (IDT) launched its Screening Dicer-substrate siRNA (DsiRNA) duplex product. Designed for small scale in vitro applications, Screening DsiRNAs provide researchers with a solution for their RNAi experiments. All duplexes are QC analyzed by ESI mass spectrometry to verify compound identity. 

Produced on IDT’s proprietary high throughput synthesis platform, the manufacturing process includes Affinity purification. Available in either tubes or plates, IDT offers a two- or 10-nanomole scale yields.

www.idtdna.com

Published in Drug Discovery & Development magazine: Vol. 11, No. 12, December, 2008, p.7.